836
BOSTON COLLEGE LAW REVIEW
[Vol.
24:835
this debate has been the problem of the high and rapidly rising cost of health
care.'
Market reform advocates argue that the excessive cost of health care is
largely attributable to structural problems in the health care delivery system
and health insurance industry, as well as to government policies that perversely
impede competition.' They contend that health care costs can best be con-
trolled by reintroducing competition into the health care sector through anti-
trust enforcement,
4
reform of health care delivery and health insurance,' and
alteration or elimination of anticompetitive government policies and
programs.' They reject direct command and control regulation as a means of
regulating cost,' arguing that it has not worked when tried,' and indeed cannot
work because of basic failures in the regulatory model.'
Vladeck,
The Market and Regulation: The Case for Regulation,
59 MILLBANK MEM. FUND Q 209
(1981); Weiner,
Reflections on Cost Containment Strategies,
59 MILLBANK MEM. FUND Q. 269 (1981)
(hereinafter cited as Weiner,
Reflections);
Weiner,
Governmental Regulation of Health Care: A Response
to Some Criticisms Voiced by Proponents of a "Free Market, "
4 AM. J. L. & MED. 15 (1978) (hereinafter
cited as Weiner,
Governmental);
and collections of essays: AMERICAN MEDICAL ASSOCIATION,
NATIONAL COMMISSION ON THE COSTS OF MEDICAL CARE
(1978);
HOSPITAL COST CONTAIN-
MENT
(M. Zubkoff, I. Raskin & R. Hanft eds. 1978); NATIONAL HEALTH INSURANCE (M. Pau-
ly ed. 1980); and A NEW APPROACH TO ECONOMICS OF HEALTH CARE,
M.
Olson ed. 1981
(hereinafter cited as NEW APPROACH).
2
See, e.g.,
ENTHOVEN, HEALTH PLAN,
supra
note 1, at xv-xvii; HAVIGHURST,
DEREGULATING,
supra
note I, at 25; Blumstein & Sloan,
supra
note 1, at 853; Bovbjerg,
supra
note I, at 965; Marmor,
supra
note 1, at 1003; Sigelman,
supra
note I, at 578. Throughout this
article "health care" will refer to care or treatment that promotes or restores human health;
"medical care" will refer more narrowly to care provided by physicians in accord with traditional
medical models.
3
See, e.g.,
ENTHOVEN, HEALTH PLAN,
supra
note 1, at 16-32; Blumstein & Sloan,
supra
note 1, at 856-58; Bovbjerg,
supra
note 1, at 967-73, 980-93; Havighurst,
Competition, supra
note 1, at 1120-25; Cohodes,
Where You Stand Depends on Where You Sit: Musings on
the
Regula-
tion/Competition Dialogue, 7
J.
HEALTH POL., POLY & L.
54, 55-61 (1982); Havighurst & Blum-
stein,
supra
note 1, at 9-30; McClure,
Structure, supra
note 1, at 139-41.
4
See,
,
Blumstein & Sloan, supra note 1, at 908-24; Havighurst,
A Comment: The
Anti-Trust Challenge to Professionalism,
41 MD. L. REV. 30 (1981); Havighurst,
Competition, supra
note 1, at 1148-49; Pollard,
supra
note 1, at 260-66.
See, e.g.,
ENTHOVEN, HEALTH PLAN,
supra
note 1; HAVIGHURST, DEREGULATING,
supra note 1, at 381-434; Bovbjerg,
supra
note 1, at 976-80; Cohodes,
supra
note 3, at 65-67; Mar-
mor, Boyer & Greenberg,
supra
note 1, at 1016-21.
See, e.g. ,
HAVIGHURST, DEREGULATING,
supra note
1, at 92-96; Blumstein & Sloan,
supra
note 1, at 867-86; McClure,
Structure, supra
note I, at 139-41.
7
See, e.g.,
ENTHOVEN, HEALTH PLAN,
supra
note 1, at 93-114; HAVIGHURST, DE-
REGULATING,
Supra
note 1, at 25-50; Blumstein & Zubkoff,
supra
note 1, at 387-93; McClure,
Im-
plementing, supra
note 1, at 17.20; McClure,
Structure, supra
note 1, at 139-42. As used in this arti-
cle command/control regulation is government regulation that relies on direct enforcement of
regulatory commands, as opposed to, e.g., use of incentives to encourage compliance.
3
See, e.g.,
Blumstein
&
Sloan,
supra
note 1, at 870-80; SLOAN & STEtNWALD,
supra
note 1, at 167-75, 193-96; Steinwald & Sloan,
Regulatory Approaches to Hospital Cost Containment: A
Synthesis of the Empirical Evidence
in NEW APPROACH,
supra
note 1, at 274.
9
See, e.g.,
ENTHOVEN, . HEALTH PLAN,
supra
note 1, at 110-13; P. FELDSTEIN,
HEALTH CARE ECONOMICS, 235-42 (1979); McClure,
supra
note 1, at 117-41; Noll,
supra
note 1,
at 28-47.